(Peer-Reviewed) Preplanned Studies: Disease Burden of Pancreatic Cancer — China, 1990−2019
Yuan He ¹ ², Xiaolong Zhou 周小龙 ², Xueqi Fan 樊雪琪 ², Bin Zhang 张斌 ² ³, Li Ma ⁴, Jing Wu 吴静 ², Xudong Li 李旭东 ⁴
¹ Baotou Medical College, Baotou, Inner Mongolia Autonomous Region, China
中国 内蒙古自治区 包头 包头医学院
² National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
中国 北京 中国疾病预防控制中心 慢性非传染性疾病预防控制中心
³ Inner Mongolia Medical University, Huhehot, Inner Mongolia Autonomous Region, China
中国 内蒙古自治区 呼和浩特 内蒙古医科大学
⁴ Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China
中国 北京 中国疾病预防控制中心 流行病学办公室
Summary
What is already known about this topic?
Pancreatic cancer is one of the most malignant tumors of the digestive tract, and the etiology is not clear. Pancreatic cancer has poor prognosis and high mortality.
What is added by this report?
Compared with 1990, the burden of pancreatic cancer in China increased significantly in 2019. In 1990 and 2019, the disease burden indicator of male pancreatic cancer was higher than that of females, and pancreatic cancer became more common as age increased, especially above 50 years old.
What are the implications for public health practices?
This study mainly provided scientific data and references for the prevention and control of pancreatic cancer in people aged 50 and above.
Multiplexed stimulated emission depletion nanoscopy (mSTED) for 5-color live-cell long-term imaging of organelle interactome
Yuran Huang, Zhimin Zhang, Wenli Tao, Yunfei Wei, Liang Xu, Wenwen Gong, Jiaqiang Zhou, Liangcai Cao, Yong Liu, Yubing Han, Cuifang Kuang, Xu Liu
Opto-Electronic Advances
2024-07-05
